Our study identified five putative plasma proteins—BLNK, CD2AP, GRN, PILRA, and PILRB—that were causally associated with AD predisposition in European-ancestry populations, highlighting their potential as diagnostic biomarkers or therapeutic drug targets. Here, CD2AP is linked to Alzheimer disease.